The Effectiveness of Different Nebulized Solutions on Airway Clearance Function in Patients With Pneumonia
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
Diagnosed with pneumonia, defined by ICD-10 codes, including:
J18: Pneumonia, unspecified organism J180: Bronchopneumonia, unspecified organism J181: Lobar pneumonia, unspecified organism J182: Hypostatic pneumonia, unspecified organism J188: Other pneumonia, unspecified organism J189: Pneumonia, unspecified organism
- Aged 18-100 years
- Clinical respiratory score > 3
- Patients unable to expectorate sputum spontaneously and requiring assisted suctioning
Exclusion Criteria:
Diagnosis of influenza-associated pneumonia, defined by ICD-10 codes, including:
J09X1: Influenza due to identified novel influenza A virus with pneumonia J1001: Influenza due to other identified influenza virus with the same identified influenza viral pneumonia J100: Influenza due to other identified influenza virus with pneumonia
Diagnosis of COVID-19 infection, defined by ICD-10 code:
U07.1: COVID-19, virus identified
- History of chronic obstructive pulmonary disease (COPD) (ICD-10 code: J44)
- History of lung cancer or metastatic cancer involving the lungs
- Current use of bronchodilators
- Patients requiring oral suctioning only
- Oxygen therapy with a flow rate > 10 L/min
- Clinical respiratory score > 8 (Table 2)
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
安慰剂比较:控制组
|
Comparison of different concentrations of saline solutions used for nebulization therapy
|
|
有源比较器:Hypertonic group
|
Comparison of different concentrations of saline solutions used for nebulization therapy
|
|
有源比较器:Isotonic group
|
Comparison of different concentrations of saline solutions used for nebulization therapy
|
|
有源比较器:Hypotonic group
|
Comparison of different concentrations of saline solutions used for nebulization therapy
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Vein blood gas
大体时间:Measurements were performed before the intervention and at 7 days after the intervention.
|
Assessment of venous blood gas values including pH, pCO₂, and HCO₃-.
|
Measurements were performed before the intervention and at 7 days after the intervention.
|
|
Sputum routine examination
大体时间:Measurements were performed before the intervention and at 7 days after the intervention.
|
Assessment of sputum characteristics and routine laboratory findings.
|
Measurements were performed before the intervention and at 7 days after the intervention.
|
|
Arterial oxygen content (CaO₂)
大体时间:Measurements were performed before the intervention and at 7 days after the intervention.
|
Measurement of arterial oxygen content calculated from hemoglobin concentration, oxygen saturation, and partial pressure of oxygen. Unit of Measure: mL O₂/dL blood |
Measurements were performed before the intervention and at 7 days after the intervention.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Blood lactic acid level
大体时间:Measurements were performed before the intervention and at 7 days after the intervention.
|
Measurement of serum lactic acid concentration.
Unit of Measure: mmol/L
|
Measurements were performed before the intervention and at 7 days after the intervention.
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.